Exploring the Framework: Investing in the Polish Medical Cannabis Market

EUROPE — While global attitudes toward cannabis shift from skepticism to acceptance, Poland, as a member of the European family, stands as a beacon of centuried cultivation, traditions, resilience, innovation, and economic growth. With its strategic location, robust economy, and forward-thinking regulatory approach, the country is cultivating more than just cannabis – it is creating a whole new realm of investment opportunities.

But what makes the medical cannabis market in Poland so attractive? Is it the rapidly evolving legal landscape opening doors for investors and entrepreneurs? The untapped potential of a market expected to increase in the coming years?

Or perhaps it’s the unique blend of benefits offered by European Union membership, the cannabis legalization movement, and the overall dynamism intrinsic to the sector? So, let’s dive into the green fields of opportunities blooming in the heart of Europe and explore why Poland is quickly becoming the go-to destination for cannabis investors with an eye for potential.

The Existing State of Affairs of Cannabis in Poland

Poland’s medical cannabis investment climate is rapidly evolving, marked by a significant shift from historical prohibition to a burgeoning regulatory framework recognizing the therapeutic potential of cannabis. Following the legalization of medical cannabis in 2017 under the bill of former rapper, longtime cannabis plant advocate, and current politician Piotr Krzysztof Liroy-Marzec, Poland has aligned its regulations with European standards, allowing for the prescription of cannabis-based medicines under strict safety and quality guidelines.

This transition not only reflects changing societal attitudes toward cannabis but also positions Poland as an emerging player in the European medical cannabis market, catching the eyes of both local and international investors seeking to capitalize on the sector’s significant potential.

While recreational use remains beyond the law, the legalization of medical cannabis is showing a steady increase in patient numbers and market value. With open trade and a green light for cannabidiol in most EU countries, Poland’s investment potential with its resource of available and experienced workforce is significant.

According to industry experts, the Polish market for CBD products is expected to reach €160.6 million by 2029, with a projected volume of €134.8 million by the end of 2024. The key factors driving this growth include:

• Increasing patient awareness and acceptance of medical cannabis treatments.
• Growing number of medical professionals willing to prescribe cannabis-based medicines.
• Expanding list of qualifying conditions for medical cannabis prescriptions.
• Rising domestic demand (particularly in the wellness industry) for high-quality, locally-produced cannabis products.

Regulatory Framework in Poland

The Polish medical cannabis industry is governed by a regulatory framework that allows for the legal sale of medical cannabis with e-receipts through pharmacies registered, authorized, and licensed by the National Ministry of Health. The country’s regulations harmonize with European standards and allow the use of cannabis for medical purposes under strict conditions.

Physicians are authorized to prescribe cannabis-based medicines, which are subject to high quality and safety standards, ensuring that they meet Good Manufacturing Practices (GMP) requirements before reaching the market.

The legal framework includes the following primary laws and regulatory bodies:

Pharmaceutical Law (Ustawa prawo farmaceutyczne). Establishes legal requirements for the manufacture, import, wholesale, and retail distribution of medicinal products, including those containing medical cannabis derivatives.

Act on Counteracting Drug Addiction (Ustawa o przeciwdziałaniu narkomanii). Provides the foundation for the legal use of medical cannabis and outlines the responsibilities of healthcare providers in prescribing it.

The President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (ORMP). Grants five-year marketing authorization for medical cannabis as a pharmaceutical raw material.

The Chief Pharmaceutical Inspector (ChPhI). Issues permits to research and scientific institutions to grow cannabis with THC levels above 0.3%.

While Poland’s regulatory framework allows for the use of medical cannabis, challenges remain, such as the lack of official guidelines on indications and dosages, and the absence of reimbursement for medical cannabis products. However, the growing number of prescriptions and the increasing amount of medical cannabis dispensed indicate a rapidly expanding market.

Exploring Business Conditions

Poland offers a compelling business landscape for medical cannabis companies, combining the advantages of an EU member state with the dynamism of an emerging market.

The country’s strong economic fundamentals, skilled workforce, and supportive government policies create an attractive operating environment for investors. Key benefits for businesses in the Polish medical cannabis sector include the following.

• Access to the broader EU market.
• Lower operational costs in national currency compared to Western European countries.
• Well-developed pharmaceutical and agricultural sectors.
• Government incentives for research and development in the cannabis industry.
• A growing ecosystem of cannabis-focused startups and support services.

Overall Medical Cannabis Investment Appeal of Poland

Poland’s unique position in the European medical cannabis scene makes it an increasingly attractive destination for investment. The country offers a combination of factors that set it apart from other markets:

1. As one of the early adopters of medical cannabis in Central Europe, Poland offers opportunities to establish strong market positions.
2. Poland is home to a highly educated workforce, particularly in fields relevant to the cannabis industry such as pharmaceuticals, agriculture, and biotechnology.
3. Located in the heart of Europe, Poland offers a gateway to both Western and Eastern European markets.
4. The government’s progressive stance on medical cannabis creates a favorable climate for industry growth and innovation.
5. Polish universities and research institutions are increasingly involved in cannabis-related studies, offering potential for industry-academia collaborations.

Cannabis, Looking Ahead: Outlook in Poland’s Medical and Recreational Markets

Poland’s medical cannabis sector offers a rare opportunity for investors looking to enter a high-potential market at a relatively early stage, ahead of the expected legalization of recreational cannabis following the example of Germany.

As the Polish medical cannabis market matures, early entrants can establish solid positions and shape the entire branch, with a tendency to interact with other industries. In this dynamic environment, the call to action is clear. Engage with local partners, invest in research, and advocate for responsible policies that promote the benefits of medical cannabis. In doing so, you will not only position yourself at the forefront of an emerging industry but also contribute to a legacy of healing and hope for patients in Poland and beyond.

—
As Poland’s medical cannabis market continues to grow, investors and cultivators across Europe are turning to Advanced Nutrients, the global leader in cannabis-specific plant nutrition. Available in over 118 countries, Advanced Nutrients offers solutions for superior crop performance, backed by over 25 years of cannabis-focused science.

Ready to boost your grow? Download our free eBook, “Inside Cultivation: Commercial Cultivation Across The Globe,” and discover how Advanced Nutrients is helping cultivators across the continent achieve success!